Stephanie Ling

1.9k total citations
16 papers, 257 citations indexed

About

Stephanie Ling is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephanie Ling has authored 16 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Spectroscopy and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephanie Ling's work include Mass Spectrometry Techniques and Applications (6 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Stephanie Ling is often cited by papers focused on Mass Spectrometry Techniques and Applications (6 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Stephanie Ling collaborates with scholars based in United Kingdom, South Korea and Australia. Stephanie Ling's co-authors include Richard J. A. Goodwin, George Poulogiannis, Grégory Hamm, Christopher J. Tape, Nicole Strittmatter, David P. Smith, Simon T. Barry, Douglas A. Lauffenburger, Maria Dimitriadi and Malcolm R. Clench and has published in prestigious journals such as Cell, Nature Communications and Analytical Chemistry.

In The Last Decade

Stephanie Ling

14 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Ling United Kingdom 7 148 88 59 44 25 16 257
Sebastian Krossa Norway 9 157 1.1× 89 1.0× 25 0.4× 48 1.1× 19 0.8× 16 272
Peiwu Huang China 11 185 1.3× 129 1.5× 50 0.8× 35 0.8× 27 1.1× 24 269
Vinay Ayyappan United States 9 221 1.5× 36 0.4× 90 1.5× 73 1.7× 44 1.8× 18 390
Ruilian Xu China 13 218 1.5× 110 1.3× 113 1.9× 111 2.5× 24 1.0× 40 388
Xavier Rovira‐Clavé United States 9 130 0.9× 28 0.3× 32 0.5× 31 0.7× 33 1.3× 14 192
Michaella J. Levy United States 11 310 2.1× 52 0.6× 29 0.5× 43 1.0× 38 1.5× 20 389
Lisa Schweizer Germany 7 208 1.4× 177 2.0× 26 0.4× 24 0.5× 18 0.7× 12 329
Sören Deininger Germany 5 239 1.6× 269 3.1× 27 0.5× 25 0.6× 10 0.4× 5 402
Editha Bayer Austria 9 262 1.8× 93 1.1× 43 0.7× 41 0.9× 59 2.4× 10 393
Xiaomeng Hu China 6 169 1.1× 62 0.7× 31 0.5× 82 1.9× 6 0.2× 8 286

Countries citing papers authored by Stephanie Ling

Since Specialization
Citations

This map shows the geographic impact of Stephanie Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Ling more than expected).

Fields of papers citing papers by Stephanie Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Ling. The network helps show where Stephanie Ling may publish in the future.

Co-authorship network of co-authors of Stephanie Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Ling. A scholar is included among the top collaborators of Stephanie Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Ling. Stephanie Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ling, Stephanie, Alex Dexter, Alan Race, et al.. (2025). Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition. Disease Models & Mechanisms. 18(2). 2 indexed citations
2.
Sushentsev, Nikita, Grégory Hamm, Stephanie Ling, et al.. (2024). Metabolic imaging across scales reveals distinct prostate cancer phenotypes. Nature Communications. 15(1). 5980–5980. 3 indexed citations
3.
Romoli, Simone, Jennifer Y. Tan, Margaret M. Huang, et al.. (2024). Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function. Kidney International. 106(1). 85–97. 11 indexed citations
4.
Ling, Stephanie, et al.. (2024). P38 Lupus enteritis as a first presentation of systemic lupus erythematosus in a previously well patient: a very rare occurrence. Rheumatology Advances in Practice. 8(Supplement_1).
5.
Strittmatter, Nicole, Alan Race, Daniel Sutton, et al.. (2022). Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution. Theranostics. 12(5). 2162–2174. 15 indexed citations
6.
Strittmatter, Nicole, R. England, Alan Race, et al.. (2021). Method to Investigate the Distribution of Water-Soluble Drug-Delivery Systems in Fresh Frozen Tissues Using Imaging Mass Cytometry. Analytical Chemistry. 93(8). 3742–3749. 6 indexed citations
7.
Dannhorn, Andreas, Stephanie Ling, Steven J. Powell, et al.. (2021). Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI). Analytical Chemistry. 93(5). 2767–2775. 5 indexed citations
8.
Guo, Fei, Andrew Hall, Christopher J. Tape, Stephanie Ling, & Amy Pointon. (2021). Intra- and intercellular signaling pathways associated with drug-induced cardiac pathophysiology. Trends in Pharmacological Sciences. 42(8). 675–687. 1 indexed citations
9.
Hamm, Grégory, Stephanie Ling, Neil A. Cross, et al.. (2021). Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry Imaging. Metabolites. 11(8). 506–506. 6 indexed citations
11.
Eyles, Jim, Amanda Watkins, Kristina M. Ilieva, et al.. (2021). Abstract 1584: Efficacy and pharmacodynamic effect of anti-CD73/PD-L1 monoclonal antibodies in combination with chemotherapy: Observations from mouse tumor models. Cancer Research. 81(13_Supplement). 1584–1584.
12.
Hamm, Grégory, Stephanie Ling, Neil A. Cross, et al.. (2020). Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging. Analytical Chemistry. 92(18). 12538–12547. 49 indexed citations
13.
Dannhorn, Andreas, Emine Kazanç, Stephanie Ling, et al.. (2020). Universal Sample Preparation Unlocking Multimodal Molecular Tissue Imaging. Analytical Chemistry. 92(16). 11080–11088. 72 indexed citations
14.
O’Connor, Lenka Oplustil, Grégory Hamm, Stephanie Ling, et al.. (2020). Abstract 6168: Characterization of ATM inhibitor (AZD1390) distribution and pharmacodynamic changes in brain and glioblastoma in preclinical models to inform on mechanism of action. Cancer Research. 80(16_Supplement). 6168–6168. 1 indexed citations
15.
Tape, Christopher J., Stephanie Ling, Maria Dimitriadi, et al.. (2016). Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation. Cell. 165(7). 1818–1818. 62 indexed citations
16.
Ling, Stephanie, et al.. (2016). Development of a multi-end point genotoxicity assessment screen (MEGA-Screen). Toxicology Letters. 258. S236–S237. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026